LONDON — The Italian drug maker Rottapharm said on Tuesday that it expected an initial public offering of its shares later this month to value the company at up to 1.8 million euros, or about $2.46 billion.
Rottapharm, which operates under the name Rottapharm|Madaus, said that it expected to price its offering of 50 million shares at €7.25 to €9 a share. The bottom end of the price range would value the company at about €1.45 billion.
Help employers find you! Check out all the jobs and post your resume.
